| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT07390383 | A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid… | Advanced Solid Tumour | Recruiting |
| NCT06783647 | A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid… | Advanced Solid Tumour | Recruiting |
| NCT07331155 | A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid… | Advanced Solid Tumour | Recruiting |
| NCT07111546 | A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid… | Advanced Solid Tumour | Recruiting |
| Phase 1/2 | |||
| NCT07281976 | A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative… | Triple Negative Breast Cancer | Recruiting |
| NCT06157827 | A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With… | Advanced Neuroendocrine Carcinoma | Recruiting |
| NCT05170958 | A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors | Advanced Solid Tumor | Recruiting |
| NCT07042802 | A Phase Ib/Ⅱ Clinical Trial of LBL-024 Combined With Paclitaxel in Patients With… | Ovarian Cancer | Recruiting |
| NCT07099430 | A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients… | Advanced Melanoma | Recruiting |